Patient-reported pain by clinical outcome in men with metastatic Castration-Resistant Prostate Cancer (mCRPC) receiving Talazoparib (TALA): TALAPRO-1 von Stenzl, A., Saad, F.S., De Bono, J.D.B., Higano, C.H., Barthelemy, P.B., Dorff, T.D., Mehra, N.M., Scagliotti, G.S., Machiels, J.M., Renard, V.R., Maruzzo, M.M., Gurney, H.G., Stirling, A.S., Healy, C.H., Bhattacharyya, H.B., Arondekar, B.A., Niyazov, A.N., Fizazi, K.F.

Volltext

Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer von Cohen, E.E.W., Licitra, L.F., Burtness, B., Fayette, J., Gauler, T., Clement, P.M., Grau, J.J., del Campo, J.M., Mailliez, A., Haddad, R.I., Vermorken, J.B., Tahara, M., Guigay, J., Geoffrois, L., Merlano, M.C., Dupuis, N., Krämer, N., Cong, X.J., Gibson, N., Solca, F., Ehrnrooth, E., Machiels, J.-P.H.

Volltext

Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomark... von Seront, E., Rottey, S., Sautois, B., Kerger, J., D'Hondt, L.A., Verschaeve, V., Canon, J.-L., Dopchie, C., Vandenbulcke, J.M., Whenham, N., Goeminne, J.C., Clausse, M., Verhoeven, D., Glorieux, P., Branders, S., Dupont, P., Schoonjans, J., Feron, O., Machiels, J.-P.

Volltext

Impact of the BioFire FilmArray gastrointestinal panel on patient care and infection control von Machiels, Julian D, Cremers, Amelieke J H, van Bergen-Verkuyten, Muriël C G T, Paardekoper-Strijbosch, Sandra J M, Frijns, Kelly C J, Wertheim, Heiman F L, Rahamat-Langendoen, Janette, Melchers, Willem J G

Volltext

Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trial von Clement, P.M., Gauler, T., Machiels, J.P., Haddad, R.I., Fayette, J., Licitra, L.F., Tahara, M., Cohen, E.E.W., Cupissol, D., Grau, J.J., Guigay, J., Caponigro, F., de Castro, G., de Souza Viana, L., Keilholz, U., del Campo, J.M., Cong, X.J., Ehrnrooth, E., Vermorken, J.B.

Volltext

Tumor Biomarker Association With Clinical Outcomes in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) Patients (Pts) Treated With Afatinib Versus Meth... von Cohen, E, Licitra, L, Burtness, B, Fayette, J, Gauler, T, Clement, P.M, Grau, J.J, del Campo, J.M, Mailliez, A, Haddad, R.I, Vermorken, J.B, Tahara, M, Guigay, J, Geoffrois, L, Merlano, M.C, Cong, X.J, Gibson, N, Solca, F, Ehrnrooth, E, Machiels, J.P.H

Volltext

PO-0765 Oncological and cosmetic outcome after IOERT as a boost in a large cohort of breast cancer patients von Machiels, M., Weytjens, R., Erven, K., Westerhoff, J.M., Amrouch, S., Bosiers, J., Verkinderen, L., Hauspy, J., Van Dam, P., Dirix, P., Vos, M., Huget, P., Dirix, L., Meijnders, P., Van Laere, S., Vermeulen, P.B., Billiet, C.

Volltext

OC-005: Afatinib versus methotrexate in recurrent/metastatic HNSCC after platinum therapy: LUX-head and neck von Clement, P, Gauler, T, Machiels, J.P.H, Haddad, R, Fayette, J, Licitra, L.F, Tahara, M, Vermorken, J.B, Cupissol, D, Grau, J.J, Guigay, J, Caponigro, F, de Castro, G, de Souza Viana, L, Keilholz, U, del Campo, J.M, Cong, X.J, Svensson, L, hrnrooth, E, Cohen, E.E.W

Volltext

Traumatic, iatrogenic, and spontaneous cerebrospinal fluid (CSF) leak: endoscopic repair von Daele, J J M, Goffart, Y, Machiels, S

Volltext

Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer von Cohen, E.E.W, Licitra, L.F, Burtness, B, Fayette, J, Gauler, T, Clement, Paul, Grau, J.J, Del Campo, J.M, Mailliez, A, Haddad, R.I, Vermorken, J.B, Tahara, M, Guigay, J, Geoffrois, L, Merlano, M.C, Dupuis, N, Krämer, N, Cong, X.J, Gibson, N, Solca, F, Ehrnrooth, E, Machiels, J.-P.H

Volltext

Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trial von Clement, Paul, Gauler, T, Machiels, J.-P.H, Haddad, R.I, Fayette, J, Licitra, L.F, Tahara, M, Cohen, E.E.W, Cupissol, D, Grau, J.J, Guigay, J, Caponigro, F, de Castro, G, de Souza Viana, L, Keilholz, U, Del Campo, J.M, Cong, X.J, Ehrnrooth, E, Vermorken, J.B

Volltext

314O_PR Second-line afatinib vs methotrexate (MTX) in patients (pts) with recurrent and/or metastatic head and neck squamous cell carcinoma (R/M HNSCC): subgroup/biomarker analysis... von Tahara, M., Cohen, E.E.W., Haddad, R.I., Fayette, J., Licitra, L.F., Clement, P.M., Vermorken, J.B., Gauler, T., Cupissol, D., Grau, J.J., Guigay, J., del Campo, J.M., Okami, K., Takahashi, S., Burtness, B., Cong, X.J., Gibson, N., Solca, F., Ehrnrooth, E., Machiels, J.-P.H.

Volltext

Afatinib Versus Methotrexate (Mtx) As Second-Line Treatment for Patients with Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (Hnscc) Who Progressed After P... von Machiels, J-P., Haddad, R.I., Fayette, J., Licitra, L.F., Tahara, M., Vermorken, J.B., Clement, P.M., Gauler, T., Cupissol, D., Grau, J.J., Guigay, J., Caponigro, F., De Castro, G., De Souza Viana, L., Keilholz, U., Del Campo, J.M., Cong, X.J., Svensson, L., Ehrnrooth, E., Cohen, E.E.W.

Volltext

LBA29_PRAFATINIB VERSUS METHOTREXATE (MTX) AS SECOND-LINE TREATMENT FOR PATIENTS WITH RECURRENT AND/OR METASTATIC (R/M) HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) WHO PROGRESSED... von Machiels, J-P., Haddad, R.I., Fayette, J., Licitra, L.F., Tahara, M., Vermorken, J.B., Clement, P.M., Gauler, T., Cupissol, D., Grau, J.J., Guigay, J., Caponigro, F., De Castro, G., De Souza Viana, L., Keilholz, U., Del Campo, J.M., Cong, X.J., Svensson, L., Ehrnrooth, E., Cohen, E.E.W.

Volltext